BACKGROUND: Single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) is a modification of Roux-en-Y duodenal switch (RYDS). Long-term data on this operation is lacking in the literature. We reviewed our mid-term data of this RYDS modification. PURPOSE: To analyze the outcomes with SADI-S at 4 years. METHODS: Data from patients who underwent a primary SADI-S procedure performed by three surgeons at a single institution from June 2013 through February 2018 were retrospectively reviewed. All revision bariatric surgeries were excluded. Regression analyses were performed for all follow-up weight loss data. RESULTS: There were 437 patients in our database. The pre-operative mean body mass index (BMI) was 49.8 ± 8.8 kg/m2. The 30-day complication rate was 7.7%. The 30-day readmission, reoperation, and mortality rates were 1.8, 1.3, and 0.2%, respectively. The long-term complication rate was 10.9%. Seventy-nine patients were 4 years post SADI-S surgery and follow-up was possible for 44 patients (55.7%). At 4 years, patients had an average change in BMI of 18.1 ± 6 units with an excess weight loss (EWL) of 85.7 ± 27.3%. At 4 years, 97.6% patients were able to maintain HbA1c < 6% with or without the use of diabetic medication. There was a statistically significant difference between most of the pre-operative and post-operative nutritional data. CONCLUSIONS: SADI-S is a safe and effective procedure in both short- and mid-term data points. Diabetes resolution and weight loss appear similar to traditional RYDS and better than RYGB.
BACKGROUND: Single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) is a modification of Roux-en-Y duodenal switch (RYDS). Long-term data on this operation is lacking in the literature. We reviewed our mid-term data of this RYDS modification. PURPOSE: To analyze the outcomes with SADI-S at 4 years. METHODS: Data from patients who underwent a primary SADI-S procedure performed by three surgeons at a single institution from June 2013 through February 2018 were retrospectively reviewed. All revision bariatric surgeries were excluded. Regression analyses were performed for all follow-up weight loss data. RESULTS: There were 437 patients in our database. The pre-operative mean body mass index (BMI) was 49.8 ± 8.8 kg/m2. The 30-day complication rate was 7.7%. The 30-day readmission, reoperation, and mortality rates were 1.8, 1.3, and 0.2%, respectively. The long-term complication rate was 10.9%. Seventy-nine patients were 4 years post SADI-S surgery and follow-up was possible for 44 patients (55.7%). At 4 years, patients had an average change in BMI of 18.1 ± 6 units with an excess weight loss (EWL) of 85.7 ± 27.3%. At 4 years, 97.6% patients were able to maintain HbA1c < 6% with or without the use of diabetic medication. There was a statistically significant difference between most of the pre-operative and post-operative nutritional data. CONCLUSIONS:SADI-S is a safe and effective procedure in both short- and mid-term data points. Diabetes resolution and weight loss appear similar to traditional RYDS and better than RYGB.
Entities:
Keywords:
4 years; Long term; Obesity; Outcomes; SADI-S; SIPS; Single anastomosis duodeno-ileal bypass with sleeve gastrectomy; Stomach intestinal pylorus-sparing surgery; Weight loss
Authors: Andrés Sánchez-Pernaute; Miguel Angel Rubio Herrera; Elia Pérez-Aguirre; Juan Carlos García Pérez; Lucio Cabrerizo; Luis Díez Valladares; Cristina Fernández; Pablo Talavera; Antonio Torres Journal: Obes Surg Date: 2007-11-27 Impact factor: 4.129
Authors: Stacy A Brethauer; Ali Aminian; Héctor Romero-Talamás; Esam Batayyah; Jennifer Mackey; Laurence Kennedy; Sangeeta R Kashyap; John P Kirwan; Tomasz Rogula; Matthew Kroh; Bipan Chand; Philip R Schauer Journal: Ann Surg Date: 2013-10 Impact factor: 12.969
Authors: Brian Mitzman; Daniel Cottam; Richie Goriparthi; Samuel Cottam; Hinali Zaveri; Amit Surve; Mitchell S Roslin Journal: Obes Surg Date: 2016-09 Impact factor: 4.129
Authors: Lars Sjöström; Markku Peltonen; Peter Jacobson; Sofie Ahlin; Johanna Andersson-Assarsson; Åsa Anveden; Claude Bouchard; Björn Carlsson; Kristjan Karason; Hans Lönroth; Ingmar Näslund; Elisabeth Sjöström; Magdalena Taube; Hans Wedel; Per-Arne Svensson; Kajsa Sjöholm; Lena M S Carlsson Journal: JAMA Date: 2014-06-11 Impact factor: 56.272
Authors: Bo T Neichoy; Bleu Schniederjan; Daniel R Cottam; Amit K Surve; Hinali M Zaveri; Austin Cottam; Samuel Cottam Journal: JSLS Date: 2018 Jan-Mar Impact factor: 2.172
Authors: Wendy A Brown; Guillermo Ponce de Leon Ballesteros; Geraldine Ooi; Kelvin Higa; Jacques Himpens; Antonio Torres; Scott Shikora; Lilian Kow; Miguel F Herrera Journal: Obes Surg Date: 2021-01-06 Impact factor: 4.129
Authors: Hinali Zaveri; Amit Surve; Daniel Cottam; Peter C Ng; Paul Enochs; Helmuth Billy; Walter Medlin; Christina Richards; LeGrand Belnap; Lindsey S Sharp; Dustin M Bermudez; Ryan Fairley; Tricia A Burns; Krista Herrell; Jaime Bull; Sophia E Menozzi; John Ambrose Student Journal: Obes Surg Date: 2019-10 Impact factor: 4.129
Authors: Daniel Moritz Felsenreich; Felix Benedikt Langer; Jakob Eichelter; Julia Jedamzik; Lisa Gensthaler; Larissa Nixdorf; Mahir Gachabayov; Aram Rojas; Natalie Vock; Marie Louise Zach; Gerhard Prager Journal: J Clin Med Date: 2021-02-10 Impact factor: 4.241